The statin wars

  title={The statin wars},
  author={T. McKillop},
  journal={The Lancet},

Topics from this paper

Mortality and other event rates: what do they tell us about performance?
  • J. Moran, P. Solomon
  • Engineering, Medicine
  • Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
  • 2003
The authors review the nexus between outcome and quality as it applies to critical care in hospitals and concludes that quality and outcome should be considered in the same context. Expand
A comparative study on the cardioprotective potential of atorvastatin and simvastatin in hyperhomocysteinemic rat hearts.
It is concluded that reductions in the high degree of oxidative stress may be responsible for the observed cardioprotective potential of Atorva-and Simvastatin, and both statins can be used interchangeably to affordCardioprotection against I/R-induced myocardial injury in normal and hyperhomocysteinemic rat hearts. Expand
Measuring and Reasoning: Numerical Inference in the Sciences
These profound principles include an understanding of the role of arithmetic and, more importantly, of how numerical patterns found in one study can relate to numbers found in others. They areExpand
Data Mining of the Public Version of the FDA Adverse Event Reporting System
The latest information on this area is summarized for future pharmacoepidemiological studies and/or pharmacovigilance analyses. Expand
Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
Signals were detected for 4 statins with respect to myalgia, rhabdomyolysis, and an increase in creatine phosphokinase level, but these signals were stronger for rosuvastatin than pravastatin and atorvastsatin, and the association was marginal. Expand
Cost‐Efficacy Analysis of 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Inhibitors Based on Results of the STELLAR Trial: Clinical Implications for Therapeutic Selection
The cost/1% reduction in low‐density lipoprotein cholesterol (LDL) and the cost/patient achieving the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) LDL goal based on the results of the STELLAR trial are compared. Expand
Statin therapy in heart failure
Statin therapy appears to improve clinical outcomes in patients with both ischemic and nonischemic cardiomyopathy independently of their cholesterol-lowering properties. Expand
The Break-Even Point: When Medical Advances Are Less Important Than Improving the Fidelity With Which They Are Delivered
It is shown that enhanced efficacy failed to achieve the health gains that would have occurred by delivering older agents to all eligible patients, and health, economic, and moral arguments make the case for spending less on technological advances and more on improving systems for delivering care. Expand
ACCF/AHA consensus conference report on professionalism and ethics.
This document summarizes current capabilities, research and operational priorities, and plans for further studies that were established at the 2015 USGS workshop on quantitative hazard assessments of earthquake-triggered landsliding and liquefaction. Expand